Gorog DA, Gue YX, Chao TF, et al. Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: a position paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the association for acute cardiovascular care and the Asia-Pacific Heart Rhythm Society. Europace. 2022;24(11):1844–71. https://doi.org/10.1093/europace/euac020.

Article  PubMed  PubMed Central  Google Scholar 

Hart RG, Diener HC, Yang S, et al. Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial. Stroke. 2012;43(6):1511–7. https://doi.org/10.1161/strokeaha.112.650614.

Article  CAS  PubMed  Google Scholar 

Budnitz DS, Shehab N, Lovegrove MC, et al. US emergency department visits attributed to medication harms, 2017–2019. JAMA. 2021;326(13):1299–309. https://doi.org/10.1001/jama.2021.13844.

Article  PubMed  Google Scholar 

Dreijer AR, Diepstraten J, Bukkems VE, et al. Anticoagulant medication errors in hospitals and primary care: a cross-sectional study. Int J Qual Health Care. 2019;31(5):346–52. https://doi.org/10.1093/intqhc/mzy177.

Article  PubMed  Google Scholar 

Aschenbrenner DS. ISMP updates high-alert medication list for acute care settings. Am J Nurs. 2024;124(5):20. https://doi.org/10.1097/01.Naj.0001016364.55411.47.

Article  PubMed  Google Scholar 

Piazza G, Nguyen TN, Cios D, et al. Anticoagulation-associated adverse drug events. Am J Med. 2011;124(12):1136–42. https://doi.org/10.1016/j.amjmed.2011.06.009.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Winterstein AG, Hatton RC, Gonzalez-Rothi R, et al. Identifying clinically significant preventable adverse drug events through a hospital’s database of adverse drug reaction reports. Am J Health Syst Pharm. 2002;59(18):1742–9. https://doi.org/10.1093/ajhp/59.18.1742.

Article  PubMed  Google Scholar 

Schwendimann R, Blatter C, Dhaini S, et al. The occurrence, types, consequences and preventability of in-hospital adverse events—a scoping review. BMC Health Serv Res. 2018;18(1):521. https://doi.org/10.1186/s12913-018-3335-z.

Article  PubMed  PubMed Central  Google Scholar 

Hazell L, Shakir SA. Under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2006;29(5):385–96. https://doi.org/10.2165/00002018-200629050-00003.

Article  PubMed  Google Scholar 

Murff HJ, Patel VL, Hripcsak G, et al. Detecting adverse events for patient safety research: a review of current methodologies. J Biomed Inform. 2003;36(1–2):131–43. https://doi.org/10.1016/j.jbi.2003.08.003.

Article  PubMed  Google Scholar 

Shuttleworth P, Baker J, Clark E. Under-reporting of gastrointestinal bleeding associated with anticoagulant use using the UK Yellow Card Scheme. Int J Clin Pharm. 2023;45(4):1014–8. https://doi.org/10.1007/s11096-023-01601-0.

Article  PubMed  Google Scholar 

Kurutkan MN, Usta E, Orhan F, et al. Application of the IHI global trigger tool in measuring the adverse event rate in a Turkish healthcare setting. Int J Risk Saf Med. 2015;27(1):11–21. https://doi.org/10.3233/jrs-150639.

Article  PubMed  Google Scholar 

Klein DO, Rennenberg R, Koopmans RP, et al. A systematic review of methods for medical record analysis to detect adverse events in hospitalized patients. J Patient Saf. 2021;17(8):e1234–40. https://doi.org/10.1097/pts.0000000000000670.

Article  PubMed  PubMed Central  Google Scholar 

Classen DC, Resar RK, Griffin F, et al. ‘Global trigger tool’ shows that adverse events in hospitals may be ten times greater than previously measured. Health Aff. 2011;30(4):581–9. https://doi.org/10.1377/hlthaff.2011.0190.

Article  Google Scholar 

Madden C, Lydon S, Curran C, et al. Potential value of patient record review to assess and improve patient safety in general practice: a systematic review. Eur J Gen Pract. 2018;24(1):192–201. https://doi.org/10.1080/13814788.2018.1491963.

Article  PubMed  PubMed Central  Google Scholar 

Brennan TA, Leape LL, Laird NM, et al. Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I. N Engl J Med. 1991;324(6):370–6. https://doi.org/10.1056/nejm199102073240604.

Article  CAS  PubMed  Google Scholar 

Griffin FA, Resar RK. IHI global trigger tool for measuring adverse events. 2nd Edition. IHI Innovation Series white paper. Cambridge: Institute for Healthcare Improvement; 2009. Available from: https://www.ihi.org/resources/white-papers/ihi-global-trigger-tool-measuring-adverse-events. Accessed 20 Mar 2025.

Musy SN, Ausserhofer D, Schwendimann R, et al. Trigger tool-based automated adverse event detection in electronic health records: systematic review. J Med Internet Res. 2018;20(5):e198. https://doi.org/10.2196/jmir.9901.

Article  PubMed  PubMed Central  Google Scholar 

Eggenschwiler LC, Rutjes AWS, Musy SN, et al. Variation in detected adverse events using trigger tools: a systematic review and meta-analysis. PLoS ONE. 2022;17(9):e0273800. https://doi.org/10.1371/journal.pone.0273800.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hibbert PD, Molloy CJ, Hooper TD, et al. The application of the global trigger tool: a systematic review. Int J Qual Health Care. 2016;28(6):640–9. https://doi.org/10.1093/intqhc/mzw115.

Article  PubMed  Google Scholar 

Davis J, Harrington N, Bittner Fagan H, et al. The accuracy of trigger tools to detect preventable adverse events in primary care: a systematic review. J Am Board Fam Med. 2018;31(1):113–25. https://doi.org/10.3122/jabfm.2018.01.170247.

Article  PubMed  Google Scholar 

Schiavo G, Forgerini M, Varallo FR, et al. Application of trigger tools for detecting adverse drug events in older people: a systematic review and meta-analysis. Res Social Adm Pharm. 2024;20(7):576–89. https://doi.org/10.1016/j.sapharm.2024.03.008.

Article  PubMed  Google Scholar 

Arab R, Cornu C, Kilo R, et al. Trigger tools to identify adverse drug events in hospitalised children: a systematic review. Therapie. 2022;77(5):527–39. https://doi.org/10.1016/j.therap.2022.01.015.

Article  PubMed  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71. https://doi.org/10.1136/bmj.n71.

Article  PubMed  PubMed Central  Google Scholar 

Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529–36. https://doi.org/10.7326/0003-4819-155-8-201110180-00009.

Article  PubMed  Google Scholar 

DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88. https://doi.org/10.1016/0197-2456(86)90046-2.

Article  CAS  PubMed  Google Scholar 

Shim SR, Kim SJ, Lee J. Diagnostic test accuracy: application and practice using R software. Epidemiol Health. 2019;41:e2019007. https://doi.org/10.4178/epih.e2019007.

Article  PubMed  PubMed Central  Google Scholar 

Petitti DB. Approaches to heterogeneity in meta-analysis. Stat Med. 2001;20(23):3625–33. https://doi.org/10.1002/sim.1091.

Article  CAS  PubMed  Google Scholar 

Borenstein M, Hedges LV, Higgins JP, et al. Introduction to meta-analysis. 2nd ed. Hoboken: Wiley; 2021.

Book  Google Scholar 

Nwulu U, Nirantharakumar K, Odesanya R, et al. Improvement in the detection of adverse drug events by the use of electronic health and prescription records: an evaluation of two trigger tools. Eur J Clin Pharmacol. 2013;69(2):255–9. https://doi.org/10.1007/s00228-012-1327-1.

Article  PubMed  Google Scholar 

Valkonen V, Haatainen K, Saano S, et al. Evaluation of Global trigger tool as a medication safety tool for adverse drug event detection-a cross-sectional study in a tertiary hospital. Eur J Clin Pharmacol. 2023;79(5):617–25. https://doi.org/10.1007/s00228-023-03469-5.

Article